DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Olsalazine

Olsalazine

  • List of Covered Drugs

    List of Covered Drugs

  • Inflammatory Bowel Disease Irritable Bowel Syndrome

    Inflammatory Bowel Disease Irritable Bowel Syndrome

  • National Quality Forum

    National Quality Forum

  • Olsalazine Is Not Superior to Placebo in Maintaining Remission Of

    Olsalazine Is Not Superior to Placebo in Maintaining Remission Of

  • Influence of Olsalazine on Gastrointestinal Transit in Ulcerative Colitis

    Influence of Olsalazine on Gastrointestinal Transit in Ulcerative Colitis

  • PRODUCT MONOGRAPH DIPENTUM ® (Olsalazine Sodium)

    PRODUCT MONOGRAPH DIPENTUM ® (Olsalazine Sodium)

  • Pharmaceutical Appendix to the Tariff Schedule 2

    Pharmaceutical Appendix to the Tariff Schedule 2

  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

    Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1

  • Disposition of 5-Aminosalicylic Acid by Olsalazine and Three Mesalazine Preparations in Patients with Ulcerative Colitis

    Disposition of 5-Aminosalicylic Acid by Olsalazine and Three Mesalazine Preparations in Patients with Ulcerative Colitis

  • Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services

    Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Use of Aminosalicylates in Diarrhoea-Predominant Irritable Bowel Syndrome

    Use of Aminosalicylates in Diarrhoea-Predominant Irritable Bowel Syndrome

  • Low Dose Balsalazide (1.5 G Twice Daily) and Mesalazine

    Low Dose Balsalazide (1.5 G Twice Daily) and Mesalazine

  • (12) United States Patent (10) Patent No.: US 7438,929 B2 Beckert Et Al

    (12) United States Patent (10) Patent No.: US 7438,929 B2 Beckert Et Al

  • Lower Gastrointestinal Tract

    Lower Gastrointestinal Tract

  • Prescription Medications, Drugs, Herbs & Chemicals Associated With

    Prescription Medications, Drugs, Herbs & Chemicals Associated With

  • Understanding IBD Medications and Side Effects Brochure

    Understanding IBD Medications and Side Effects Brochure

  • Pharmecovigilance and the Environmental Footprint of Pharmaceuticals Ilene S

    Pharmecovigilance and the Environmental Footprint of Pharmaceuticals Ilene S

Top View
  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021
  • Therapeutic Class Overview Inflammatory Bowel Disease Agents
  • Ulcerative Colitis
  • Aminosalicylates
  • Ulcerative Colitis Agents Therapeutic Class Review (TCR)
  • Statistical Analysis Plan / Data Specifications the Risk of Acute Liver Injury Associated with the Use of Antibiotics. a Replica
  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
  • Olsalazine Versus Placebo in the Treatment of Mild to Moderate Ulcerative Colitis: a Randomised Double Blind Trial
  • Brand Generic Guide
  • 21324 Budesonide Clinical PREA
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • Disease of the Colon
  • Therapeutic Class Overview Ulcerative Colitis Agents
  • U Lcerative Co Litis N Atio N Al C Lin Ical G U Id Elin E C En Tre, 20 13
  • Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
  • Mesalazine (Pentasa, Asacol, Salofalk) Olsalazine
  • DIPENTUM® (Olsalazine Sodium Capsules) Rx Only
  • Section a Changed Classes/Guidelines


© 2024 Docslib.org    Feedback